Loading…
Patient Access to ESRD New Innovative Devices Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Patient Access to ESRD New Innovative Devices Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish a process to provide a certain payment adjustment under the Medicare end-stage renal disease (ESRD) prospective payment system. Specifically, the CMS must establish a process to provide for a temporary add-on payment adjustment for new medical devices used to diagnose, treat, or manage ESRD.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2020 · fourth_quarter · Medicare/Medicaid
HR 2710/S2751, Patient Access to ESRD New Innovative Devices Act, new tech innovation and increased access to home dialysis. CARES Act, P.L. 116-136, as it relates to home dialysis during public health emergency.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $410,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2020 · fourth_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. H.R. 2710 / S.2751, Patient Access to ESRD New Innovative Devices Act, S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the strategic national stockpile. Issues related to home dialysis and the Presidents Advancing American Kidney Health Initiative (AAKHI), and the ESRD Treatment Choices model. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R. 925 / H.R. 8406, The HEROES Act. Monitored S. 4317, SAFE TO WORK Act. Monitored S. 4322, Safely Back to School and Back to Work Act. H.R. 133, The Consolidated Appropriations Act of 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Medicare/Medicaid
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710 / S. 2751, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home and the Presidents Advancing American Kidney Health Initiative (AAKHI).
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · second_quarter · Medicare/Medicaid
HR 2710/S2751, Patient Access to ESRD New Innovative Devices Act, new tech innovation and increased access to home dialysis. CARES Act, P.L. 116-136, as it relates to home dialysis during public health emergency.
Client expense: $370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2020 · third_quarter · Health Issues
Monitored issues related to pharmaceutical prices. Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. H.R. 2710 / S.2751, Patient Access to ESRD New Innovative Devices Act, S. 1895, Lower Health Care Costs Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages and product sterilization. Issues regarding the strategic national stockpile. Issues related to home dialysis and the Presidents Advancing American Kidney Health Initiative (AAKHI), and the ESRD Treatment Choices model. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R. 925 / H.R. 8406, The HEROES Act. Monitored S. 4317, SAFE TO WORK Act. Monitored S. 4322, Safely Back to School and Back to Work Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · third_quarter · Medicare/Medicaid
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710 / S. 2751, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home and the Presidents Advancing American Kidney Health Initiative (AAKHI).
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · third_quarter · Medicare/Medicaid
HR 2710/S2751, Patient Access to ESRD New Innovative Devices Act, new tech innovation and increased access to home dialysis. CARES Act, P.L. 116-136, as it relates to home dialysis during public health emergency.
Client expense: $550,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2020 · second_quarter · Health Issues
Centers for Medicare & Medicaid Service End-Stage Renal Disease Prospective Payment System, transitional add-on payment adjustment for new and innovative equipment and supplies. Centers for Medicare and Medicaid Innovation. End-Stage Renal Disease Treatment Choices Model and Kidney Care First (KCF) and Comprehensive Kidney Care Contracting (CKCC) voluntary models. Patient Access to ESRD Innovative Devices (S. 2751) Medicare End-stage Renal Disease Conditions for Coverage
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · second_quarter · Medicare/Medicaid
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Client expense: $2,120,000 · Firm income: Not reported
2020 · second_quarter · Medicare/Medicaid
HR 2710/S2751, Patient Access to ESRD New Innovative Devices Act, new tech innovation and increased access to home dialysis. CARES Act, P.L. 116-136, as it relates to home dialysis during public health emergency.
Client expense: $370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2020 · second_quarter · Medicare/Medicaid
Centers for Medicare & Medicaid Service End-Stage Renal Disease Prospective Payment System, transitional add-on payment adjustment for new and innovative equipment and supplies; Patient Access to ESRD Innovative Devices (S. 2751); Coronavirus Aid, Relief, and Economic Security Act or the CARES Act (H.R. 748).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Medicare/Medicaid
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Client expense: $3,460,000 · Firm income: Not reported
2020 · first_quarter · Health Issues
Centers for Medicare & Medicaid Service End-Stage Renal Disease Prospective Payment System, transitional add-on payment adjustment for new and innovative equipment and supplies. Centers for Medicare and Medicaid Innovation. End-Stage Renal Disease Treatment Choices Model and Kidney Care First (KCF) and Comprehensive Kidney Care Contracting (CKCC) voluntary models. Patient Access to ESRD Innovative Devices (S. 2751) Medicare End-stage Renal Disease Conditions for Coverage
Client expense: $76,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · first_quarter · Medicare/Medicaid
Centers for Medicare & Medicaid Service End-Stage Renal Disease Prospective Payment System, transitional add-on payment adjustment for new and innovative equipment and supplies; Patient Access to ESRD Innovative Devices (S. 2751); Coronavirus Aid, Relief, and Economic Security Act or the CARES Act (H.R. 748)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Medicare/Medicaid
HR 2710/S2751, Patient Access to ESRD New Innovative Devices Act, new tech innovation and increased access to home dialysis. CARES Act, P.L. 116-136, as it relates to home dialysis during public health emergency.
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2019 · fourth_quarter · Medicare/Medicaid
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
Client expense: $2,262,000 · Firm income: Not reported
2019 · fourth_quarter · Medicare/Medicaid
ESRD new tech innovation and increased access home dialysis. HR 2710/S 2751, Patient Access to ESRD New Innovative Devices Act, regarding all provisions.
Client expense: $400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Health Issues
Centers for Medicare & Medicaid Service End-Stage Renal Disease Prospective Payment System, transitional add-on payment adjustment for new and innovative equipment and supplies. Centers for Medicare and Medicaid Innovation . End-Stage Renal Disease Treatment Choices Model and Kidney Care First (KCF) and Comprehensive Kidney Care Contracting (CKCC) voluntary models. Patient Access to ESRD Innovative Devices (S. 2751)
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), SENATE
| Democratic |
| DE |
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office